Results 41 to 50 of about 707 (123)
Diagnosis, prognosis and evaluation of death risk in Chagas cardiomyopathy still constitute a challenge due to the diversity of manifestations, which determine the importance of using echocardiography, tissue Doppler and biomarkers. To evaluate, within a
Clodoval de Barros Pereira Júnior +1 more
doaj +1 more source
sVCAM‐1 and Hematological Profiles Are Associated With CD4‐Defined Disease Status in HIV Infection
ABSTRACT Brazil stands out for its progressive public health policies against HIV, including universal access to antiretroviral therapy and a stricter AIDS definition (CD4 < 350 cells/mm3) compared to the World Health Organization (WHO) criterion (CD4 ≤ 200 cells/mm3).
Bruno Almeida‐Silva +8 more
wiley +1 more source
ABSTRACT Objective To analyse mortality, hospitalisations and in‐hospital mortality related to paracoccidioidomycosis (PCM) in Brazil, 2000–2024, from a spatio‐temporal and social inequalities perspective. Methods We conducted a mixed ecological study using death certificates from the Mortality Information System and hospital admissions from the ...
Anderson Fuentes Ferreira +9 more
wiley +1 more source
Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements
There is ample experimental and clinical evidence of functional and structural microvascular abnormalities occurring in patients with Chagas cardiomyopathy, possibly due to the inflammatory process and/or autonomic disturbances caused by Trypanosoma ...
Jose Antonio Marin-Neto +2 more
doaj +1 more source
Chagas cardiomyopathy, caused by chronic infection with Trypanosoma cruzi , is a leading cause of non-ischaemic heart failure in Latin America and is increasingly recognised worldwide due to migration.
Maria Carmo Pereira Nunes +8 more
openaire +3 more sources
Despite matched clinical characteristics and LVEF, patients with Chagas cardiomyopathy exhibit a significantly higher arrhythmic burden compared to ischemic cardiomyopathy. This electro‐mechanical dissociation highlights the necessity of sudden death risk stratification strategies that extend beyond traditional ejection fraction thresholds.
Luis E. Echeverría +7 more
wiley +1 more source
Chagas disease continues to be a significant public health problem, as ca. 10 million people are still infected with T. cruzi in Latin America. Decades after primary infection, 30% of individuals can develop a form of chronic inflammatory cardiomyopathy ...
Angelina M.B. Bilate, Edecio Cunha-Neto
doaj +1 more source
Current Topics of Progressive Cardiac Conduction Disease
Many genes and the protein cause PCCD. Mutation of NaV1.5 or CX40 cause isolated PCCD, but mutation of lamin A/C, emerin, or desmin lead to cardiomyopathy, and PCCD. Mutation of transcription factor NCX2‐5, and Tbx5 associated with atrial septal defect and abnormal development of conduction system.
Naokata Sumitomo +7 more
wiley +1 more source
Ex vivo T-lymphocyte chemokine receptor phenotypes in patients with chronic Chagas disease
INTRODUCTION: Elucidating the molecules involved in the inflammatory process of chronic Chagas disease may allow identification of treatment targets.
Matheus Barbosa de Miranda +5 more
doaj +1 more source
Chagas cardiomyopathy (ChCM) is a severe consequence of Trypanosoma cruzi infection and has a range of electrocardiographic (ECG) and echocardiographic (ECHO) manifestations. There is a need for a standard and parsimonious research cardiac end point that
Lewis F. Buss +6 more
doaj +1 more source

